Use of Adenovirus Vectors Expressing Epstein-Barr Virus (EBV) Immediate-Early Protein BZLF1 or BRLF1 To Treat EBV-Positive Tumors

The Epstein-Barr virus (EBV) genome is present in a variety of tumor types, including virtually all undifferentiated nasopharyngeal carcinomas (NPC) and a portion of gastric carcinomas. The uniform presence of the EBV genome in certain tumors (versus only a very small number of normal B cells) sugge...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	J Virol
Autori principali:	Feng, Wen-hai, Westphal, Eva, Mauser, Amy, Raab-Traub, Nancy, Gulley, Margaret L., Busson, Pierre, Kenney, Shannon C.
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 2002
Soggetti:	Gene Therapy
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC136642/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12368338/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.76.21.10951-10959.2002
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!